Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/11000/40578

High‑dose benzodiazepine use and QTc interval prolongation, a latent class analysis study


thumbnail_pdf
Ver/Abrir:
 High‑dose benzodiazepine use.pdf

979,94 kB
Adobe PDF
Compartir:
Título :
High‑dose benzodiazepine use and QTc interval prolongation, a latent class analysis study
Autor :
Zamboni, Lorenzo  
Portoghese, Igor  
casari, rebecca
Fusina, Francesca
Santin, Laura  
Lecca, Luigi Isaia
Campagnari, Simone  
Carli, Silvia  
Zandonai, Thomas  
Lugoboni, Fabio  
Editor :
Nature
Departamento:
Departamentos de la UMH::Farmacología, Pediatría y Química Orgánica
Fecha de publicación:
2024
URI :
https://hdl.handle.net/11000/40578
Resumen :
Benzodiazepine (BDZ) addiction is a widespread and multifaceted phenomenon. For many patients, especially females, the concomitant use of other drugs also increases their risk of QTc prolongation, possibly leading to complications such as seizures and even sudden death. However, the relationship between BDZ use and QTc prolongation is currently unclear. The present study aims to examine patterns of polysubstance use among a sample of Italian adults with BDZ dependence in relation with their QTc prolongation risk. We used Latent Class Analysis (LCA) on data collected from 251 inpatients of the Addiction Medicine Unit in Verona to group patients into three classes according to their substance use and their QTc prolongation risk. Results showed no significant relationship between QTc prolongation and BDZ use in any of the classes considered. We conclude that BDZs, even if used long-term and at high dosages, can be considered safe in terms of cardiovascular complications for patients.
Palabras clave/Materias:
benzodiazepine
QTc interval prolongation
Tipo de documento :
info:eu-repo/semantics/article
Derechos de acceso:
info:eu-repo/semantics/openAccess
Attribution-NonCommercial-NoDerivatives 4.0 Internacional
DOI :
10.1038/s41598-023-50489-3
Publicado en:
Scientific Reports | (2024) 14:155
Aparece en las colecciones:
Artículos - Farmacología, Pediatría y Química Orgánica



Creative Commons La licencia se describe como: Atribución-NonComercial-NoDerivada 4.0 Internacional.